Oxford Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Oxford Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,040,297	Closed	-$5.78M	–	1988
2017 Q3	$5.78M	Buy	2,040,297 +608,402	+42%	+$2.08M	0.11%	190
2017 Q2	$6.37M	Buy	+1,431,895	New	+$5.9M	0.13%	166
2016 Q1	–	Sell	-194,406	Closed	-$1.1M	–	971
2015 Q4	$1.1M	Buy	+194,406	New	+$1.19M	0.03%	516
2014 Q2	–	Sell	-414,311	Closed	-$2.2M	–	826
2014 Q1	$2.2M	Sell	414,311 -73,838	-15%	-$414K	0.06%	344
2013 Q4	$2.71M	Buy	+488,149	New	+$2.1M	0.07%	360

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Oxford Asset Management's SGYP Position: Q4 2017 in Review

Oxford Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2017, closing a stake of 2,040,297 shares — an estimated $5.78M sold.

Oxford Asset Management first reported a position in SGYP in Q4 2013 and held it in 5 quarters. The position peaked at $6.37M in Q2 2017. 150 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

Oxford Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2017 after selling out during the quarter.
Oxford Asset Management sold 2,040,297 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2017, an estimated $5.78M.
Oxford Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2013 and held it in 5 quarters.
Oxford Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $6.37M in Q2 2017.
150 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2017.

Based on Oxford Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.